← All Sponsors

SPONSOR

ITM Solucin GmbH

Total Trials

1

Recruiting

1

Phases

Phase 1

Conditions studied: Somatostatin Receptor Positive NETs Lymphoma Solid Tumor CNS Tumors Rhabdomyosarcoma Peripheral Primitive Neuroectodermal Tumor GIST

NCT06441331 Phase 1

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

Somatostatin Receptor Positive